Stability studies: pull points, results and specification limits.

• Missed Pull-Points Invalidate the Study

  Someone forgets the 6-month pull on chamber 3. That timepoint is gone. So is the shelf-life claim.

• Trend Analysis Lives in Excel

  Assay values are typed twice — once in the LIMS, once in the stability tracker — with no version control and no e-signature on the trend line.

• Shelf-life extrapolation is a copy-paste job

  The Q1E regression is done by hand on the day the report is due. Auditors ask to see the raw dataset. Nobody knows where it is.

• Protocol-Driven Pull-Point Scheduling

  Long-term (25°C/60%RH), intermediate (30°C/65%RH), accelerated (40°C/75%RH), refrigerated, freezer — every timepoint calendared with role-based alerts and escalation on overdue.

• Direct LIMS Link — No Re-Keying

  Assay, impurities, dissolution, water content flow from the LIMS into the stability record; specification limits enforced automatically.

• ICH Q1E Regression Built In

  Linear, log, reciprocal regression with confidence intervals, retest date and shelf-life recommendation — with the underlying dataset preserved for the reviewer.

• OOS on Stability Triggers Investigation with Hold

  A failing timepoint opens an OOS investigation, holds the batch in commerce, and flags every batch on the same specification.

• Submission-Ready Report

  ICH-format stability summary, tabulated data, regression plots, chamber qualification appendix, exported as PDF/A.

Stability in V5.

1. Protocol under Change Control. Attributes, intervals, conditions, design captured.
2. Batches Enrolled. Chamber assignments and sample counts derived.
3. Scheduled Pulls Executed. Pre-notification, execution capture, missed-pull record if applicable.
4. Results captured. LIMS interface or in-system capture.
5. Q1E Analysis. Live regression; shelf-life estimates updated.
6. Regulatory-Ready Output. Signed report per protocol.

Stability studies fail on scheduling, chamber excursions, and pull integrity. Criteria below matter more than the pretty charts.

• Pull Schedule Enforcement

  Are pull points scheduled with pre-notification and missed-pull records? Schedule per protocol with pre-notification; missed pull is a first-class record.

• Chamber Excursion Linkage

  Do excursions link to the samples in the chamber? Chamber telemetry linked; affected samples surfaced.

• Trend Against ICH Q1E

  Are trends analysed per ICH Q1E for shelf-life determination? Q1E-aware regression per attribute.

• Bracketing / Matrixing

  Are Q1D bracketing and matrixing designs supported? Q1D designs native.

• OOS at Stability

  Do OOS at stability route to full OOS workflow? Stability OOS uses the same OOS lifecycle.

Stability tooling.

ICH Q1 series expectations.

• ICH Q1A(R2)

  Native protocol modelling with intervals and conditions.

• ICH Q1E

  Regression, ANCOVA and shelf-life estimation native.

• ICH Q1D

  Both designs supported with rationale capture.

• 21 CFR 211.166

  Written program is the executed protocol in V5.

• ICH Q1A(R2) (stability testing of new drug substances and products)
• ICH Q1E (evaluation of stability data)
• 21 CFR 211.166 (stability testing)
• EU GMP Annex 19 (reference and retention samples)
• WHO TRS 1010 Annex 10 (stability of pharmaceutical products)

• Pharmaceuticals
• Biotech
• Nutraceuticals
• Cosmetics
• Lab QC
• Sensors & IoT Monitoring
• Equipment Calibration
• ICH Q1A Storage Conditions
• Expiry vs Retest Date
• ICH Q1A

Does V5 handle chamber mapping and qualification?

Yes — chamber IQ/OQ, temperature/humidity mapping profiles, and continuous monitoring alarms are linked to every study; excursions auto-flag the affected timepoints.

Can V5 support bracketing and matrixing designs?

Yes, per ICH Q1D. The protocol builder captures the reduced design, the statistical justification, and the residual coverage — audit-defensible.

What about bulk / API stability?

Same engine. Bulk API, drug substance, drug product, finished dose, and repackaged/relabelled product all run as protocol variants.